SIASUN(SZ:300024) Mei Ri Jing Ji Xin Wen·2025-10-23 01:20Market Overview - The Huaxia Sci-Tech AI ETF (589010) experienced a slight increase of 0.07%, closing at 1.420 yuan, with a trading volume of 96.987 million shares and a turnover of approximately 137 million yuan, indicating good liquidity [1] - Among the 30 constituent stocks, 10 rose while 20 fell, showing significant structural differentiation, with notable performers including Cambricon, Hehe Information, and Stone Technology, primarily in the computing power and application sectors [1] - The Robot ETF (562500) rose by 0.20%, closing at 1.010 yuan, slightly outperforming the CSI Robot Index, with a trading volume of approximately 1.107 billion yuan [1] - In the Robot ETF, 30 out of 73 constituent stocks increased while 43 decreased, with the top gainers being Keri Technology and CITIC Heavy Industries, both hitting the daily limit of 10% [1] - The market has seen a net inflow of 4.3 billion yuan into the AI ETF and 7.5 billion yuan into the Robot ETF over the past five days, indicating sustained market interest despite fluctuations [1] Industry News - The International Conference on Intelligent Robots and Systems (IROS 2025) was held in Hangzhou from October 21 to 23, showcasing Fourier's latest humanoid robots, GR-3 and the open-source humanoid robot N1, with GR-3 introducing the "Care-bot" concept [2] - The Guangdong Provincial Government announced an action plan for high-quality development of manufacturing powered by AI, aiming for over 20 billion yuan in AI-related investments by 2027, which is expected to drive the related industry scale beyond 100 billion yuan [2] Company Developments - Jitai Technology announced that its AI-driven small molecule formulation optimization platform, AiTEM, has successfully reached the primary endpoint of Phase III clinical trials for the candidate drug MTS-004, marking it as the first AI-enabled formulation new drug to complete Phase III trials in China [3] - MTS-004 is also the first and only drug to complete Phase III trials for Pseudobulbar Affect (PBA) in China, potentially filling a gap in the domestic market for PBA treatment [3] Institutional Insights - CITIC Securities noted that the humanoid robot sector has retraced its gains from September, with current fundamentals progressing normally, and short-term adjustments attributed to tariff increase expectations affecting tech growth [4] - The upcoming Tesla Q3 report on October 23 and the shareholder meeting on November 7 are seen as critical observation points for the sector [4] - The current market pullback due to liquidity fluctuations is viewed as a buying opportunity, with stocks exceeding expectations in Q3 performance and robot business progress being preferred for allocation [4] Popular ETFs - The Robot ETF (562500) is the only ETF in the market with a scale exceeding 20 billion yuan, offering the best liquidity and comprehensive coverage of the Chinese robot industry chain [5] - The Huaxia Sci-Tech AI ETF (589010) is positioned as the "brain" of robotics, with a 20% price fluctuation limit and small-cap elasticity, aimed at capturing the "singularity moment" in the AI industry [5]